5/21/2020 | HY | New Issue: PPD prices upsized $1.2 billion senior notes in revised two-part deal
|
5/21/2020 | HY | PPD talks $700 million eight-year senior notes to yield 5%-5¼%; pricing Thursday
|
8/5/2015 | HY | Market Commentary: Upsized First Data drive-by leads biggest primary day since June; new Party City jumps
|
10/15/2012 | HY | Market Commentary: Nortek, Nuance bring add-ons; Vantage megadeal on tap; Sprint jumps on sale to Softbank
|
10/11/2012 | HY | Market Commentary: Momentive mega-deal, Cequel, BI-LO price; Sprint up on Softbank news; funds lose $114 million
|
10/10/2012 | BKDDHY | Moody's cuts Pharmaceutical, rates Holdco notes Caa1
|
10/10/2012 | HY | Jaguar Holding to sell $500 million five-year PIK toggle notes
|
10/10/2012 | HY | New Issue: PPDI prices upsized $525 million five-year PIK toggle notes
|
10/10/2012 | HY | Market Commentary: TransDigm, CVR, Shelf Drilling lead $2 billion primary; AMR trades off; confab stills market
|
10/10/2012 | BKDDHY | S&P lowers Pharmaceutical Product, rates notes CCC+
|
11/17/2011 | HY | Market Commentary: No pricings, but market awaits Kodiak, Entercom; new deals in narrow range; Jefferies jarred
|
11/16/2011 | HY | Market Commentary: Drive-by Plains mega-deal, American Greetings, Atlas Pipeline price; ATP, MF Global gain
|
11/15/2011 | HY | New Issue: Pharmaceutical Product Development sells $575 million 91/2% eight-year notes at par
|
11/15/2011 | HY | Market Commentary: Swift, upsized Pioneer Drilling, downsized Pharmaceutical Product price; ATP agony continues
|
11/15/2011 | BKHY | Moody's: Pharmaceutical Product unchanged
|
11/15/2011 | BKHY | S&P: Pharmaceutical Product unchanged
|
11/14/2011 | BKHY | S&P rates Pharmaceutical Product loans BB-, notes B
|
11/14/2011 | BKHY | Moody's rates Pharmaceutical Product loans Ba3, notes B3
|
11/14/2011 | HY | Market Commentary: Community Health, Host Hotels price drive-bys; ATP Oil eroding; ResCap up ahead of coupon
|
11/9/2011 | HY | Market Commentary: Petroleum Geo, Green Field price; market mostly off as stocks slide; ResCap, ATP big losers
|
11/9/2011 | HY | Pharmaceutical Product to sell $700 million eight-year notes
|
11/4/2011 | HY | Level 3 loans rise; Pharmaceutical Product sets launch, talk; Asset Acceptance tweaks
|
10/24/2011 | HY | Market Commentary: Junk surges broadly, but mortgage-insurers fall; market awaits re-worked Chesapeake, Kinetic
|
10/14/2011 | HY | Pharmaceutical Product Development LBO to include $700 million notes
|